TV News LIES

Tuesday, Nov 21st

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Hidden camera shows how WWII veteran died after calling for help, gasping for air

James Dempsey dies gasping for air in nursing homeA decorated World War II veteran died gasping for breath while staff at his nursing home...

Researchers: CTE was detected in living former NFL player

CTE found in living football player For the first time, research has confirmed that scientists successfully detected chronic traumatic encephalopathy --...

Legionnaires' cases linked to Disneyland expand to 15

Legionnaire's disease at Disneyland rises to 15 Health officials in California on Thursday said the number of cases of Legionnaires' disease in...

A Man Gets His Genes Edited, and Science Waits With Bated Breath

man has genes edited For the first time ever, scientists have edited genes inside a person in an attempt to...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!